Hemant Surgical AGM resolutions pass with 100% support

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • All three ordinary resolutions at the 37th AGM passed with 100% votes in favour
  • Total votes polled stood at 8,292,000, representing 57.04% of outstanding shares
  • Promoter group voted 100% of their holding (7,680,000 shares) in favour of all items
  • No dissenting or invalid votes were recorded across any resolution category
powered bylight_fuzz_icon
52239882

*this image is generated using AI for illustrative purposes only.

Hemant Surgical Industries Limited shareholders unanimously approved all three ordinary resolutions at the company's 37th Annual General Meeting held on September 29, 2026.

The scrutinizer, Nikita Kedia of NKM & Associates, reported that 8,292,000 valid votes were cast in favour of each resolution, with zero dissenting or invalid votes. This turnout represented 57.04% of the total outstanding shares.

Voting outcome details

The meeting, conducted via Video Conferencing and Other Audio-Visual Means, saw participation from 16 shareholders virtually. The breakdown of voting across shareholder categories for each resolution was as follows:

Resolution Votes Polled % of Outstanding Shares In Favour Against Result
Adoption of FY26 Financial Statements 8,292,000 57.04% 8,292,000 0 Passed
Re-appointment of Hemant Praful Shah 8,292,000 57.04% 8,292,000 0 Passed
Ratification of Cost Auditor Remuneration 8,292,000 57.04% 8,292,000 0 Passed

Promoters and promoter group voted 100% of their holding (7,680,000 shares) in favour of all resolutions. Public institutions voted 400,000 shares (13.80% of their holding), while public non-institutions voted 212,000 shares (5.36% of their holding).

Key resolutions passed

The following ordinary resolutions were presented to and approved by the shareholders:

  1. Adoption of audited standalone and consolidated financial statements for FY26.
  2. Re-appointment of Hemant Praful Shah as a Director, retiring by rotation.
  3. Ratification of remuneration for cost auditors.

Meeting proceedings and attendance

The meeting commenced at 12:30 pm and concluded at 1:15 pm, including a 15-minute e-voting window. A quorum was constituted by 16 shareholders present virtually. The scrutinizer was Nikita Kedia of NKM & Associates.

Key managerial personnel present included:

  • Hanskumar Shamji Shah, Chairman & Managing Director
  • Hemant Praful Shah, Whole-Time Director
  • Kaushik Hanskumar Shah, CFO & Whole-Time Director

Governance and compliance details

Particular Detail
Date of AGM September 29, 2026
Mode of Meeting Video Conferencing / OAVM
Platform Provider National Securities Depository Limited
Cut-off Date for Voting September 22, 2026
E-voting Period September 26, 2026 to September 28, 2026

The results of the voting have been declared based on the scrutinizer's report and published on the company website and stock exchange portals.

Historical Stock Returns for Hemant Surgical Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+1.39%+19.48%+60.40%+144.91%+82.88%+231.38%

How will the adoption of the FY26 financial statements impact Hemant Surgical's upcoming capital allocation strategy or dividend policy?

What specific growth initiatives or market expansions is Hemant Praful Shah expected to prioritize following his re-appointment as Whole-Time Director?

Given the low participation rate of public non-institutional shareholders (5.36%), what steps might the company take to improve retail investor engagement in future meetings?

Hemant Surgical Industries
View Company Insights
View All News
like19
dislike

Hemant Surgical approves FY26 report, schedules 37th AGM

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Hemant Surgical Industries approved its Directors' Report for FY26
  • The 37th AGM is scheduled for September 29, 2026, via video conference
  • Board meeting concluded on August 29, 2026, in compliance with SEBI regulations
powered bylight_fuzz_icon
49532916

*this image is generated using AI for illustrative purposes only.

Hemant Surgical Industries approved its Directors' Report and Management Discussion and Analysis for the financial year ended March 31, 2026. The board also scheduled the company's 37th Annual General Meeting.

The meeting of the Board of Directors was held on Saturday, August 29, 2026. It commenced at 11:50 am and concluded at 12:10 pm. The approvals were made in compliance with Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Annual General Meeting Details

The company will hold its 37th AGM on Tuesday, September 29, 2026. The meeting is scheduled to begin at 12:30 pm. Shareholders can attend through Video Conferencing or Other Audio-Visual Means.

The Managing Director, Hanskumar Shamji Shah, signed the disclosure filed with BSE Limited.

Historical Stock Returns for Hemant Surgical Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+1.39%+19.48%+60.40%+144.91%+82.88%+231.38%

What specific strategic initiatives or growth targets did the Management Discussion and Analysis highlight for the fiscal year 2027?

How is Hemant Surgical Industries planning to navigate potential supply chain disruptions or raw material cost fluctuations in the global surgical instruments market?

Are there any pending regulatory approvals or new product launches expected to drive revenue growth in the upcoming quarters?

Hemant Surgical Industries
View Company Insights
View All News
like15
dislike

More News on Hemant Surgical Industries

1 Year Returns:+82.88%